Loxo Oncology Announces Pricing of Initial Public Offering

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Loxo Oncology Announces Pricing of Initial Public Offering

STAMFORD, Conn., Aug. 1, 2014 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced the pricing of its initial public offering of 5,261,538 shares of its common stock at a price to the public of $13.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 1, 2014 under the symbol "LOXO." In addition, Loxo Oncology has granted the underwriters a 30-day option to purchase up to 789,230 additional shares of common stock from Loxo Oncology at the same price to cover over-allotments, if any. Concurrently with the offering, the Company is also selling through a private placement 230,769 shares of its common stock to New Enterprise Associates 14, L.P., an existing stockholder, at the initial public offering price.

Cowen and Company, LLC and Stifel are acting as joint book-running managers for the offering. JMP Securities LLC and Oppenheimer & Co. Inc. are acting as co-managers.

A registration statement relating to the securities to be sold in the offering has been filed with the U.S. Securities and Exchange Commission and was declared effective on July 31, 2014.

The offering will be made only by means of a prospectus. Copies of the final prospectus related to the offering may be obtained, when available, from Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (631) 274-2806 or by fax at (631) 254-7140; or from Stifel, Nicolaus & Company, Inc., Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, telephone: (415) 364-2720, email: syndicateops@stifel.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Jacob S. Van Naarden Vice President, Corporate Development and Strategy Peter Rahmer The Trout Group, LLC 646-378-2973

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 1

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 2

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 2

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 3

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 3

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 1

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 2

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 2

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

John B. Sanfilippo & Son Announces Major $1.00 Special Dividend

Updated Category News Views 156

John B. Sanfilippo & Son Declares Special $1.00 Dividend The management of John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) has exciting news for its shareholders as the company has declared a special cash dividend of $1.00 per share. This amount will be distributed on shares of both Common Stock and Class A Common Stock, which is expected to return about $11.7 million to...

Continue Reading
Recent Disclosure Submission by De La Rue plc Explained

Updated Category News Views 262

Understanding Recent Disclosure Submissions Corporations frequently engage in the process of disclosing financial information to ensure transparency and compliance with market regulations. Among these, De La Rue plc, a prominent player in the printing and security technology sector, has made an important disclosure pertaining to trades conducted by its exempt principal...

Continue Reading
Perrigo Company Engages Investors at Upcoming Conference

Updated Category News Views 114

Perrigo Company Engages Investors at Upcoming Conference Dublin - Perrigo Company plc (NYSE: PRGO), renowned for its commitment to consumer health products, has announced that its President and CEO, Patrick Lockwood-Taylor, along with CFO Eduardo Bezerra, will participate in one-on-one investor meetings at the Jefferies Miami Consumer Conference. This event is set to...

Continue Reading
Hellas Verona Partners with Veronafiere for Chicago Event

Updated Category News Views 281

Hellas Verona and Veronafiere Collaborate for Vinitaly.USA Hellas Verona Football Club and Veronafiere are excited to announce their latest partnership, aimed at promoting the finest of Italian wines on an international platform. This collaboration emphasizes the upcoming second edition of Vinitaly.USA, a prestigious event highlighting Italian wine in the United States,...

Continue Reading
Bio-Techne to Showcase Innovations at Annual Healthcare Event

Updated Category News Views 159

Bio-Techne Corporation to Present at Key Healthcare Conference Bio-Techne Corporation (NASDAQ: TECH) is set to take the stage at a prestigious annual healthcare conference. With a focus on innovation and providing indispensable tools for the medical and research communities, Bio-Techne's President and CEO, Kim Kelderman, will share insights on January 14, 2025. This event...

Continue Reading